Providers Coverage Costs Reference

23/51 states verified · 14/25 providers audited

Medicaid coverage

New Hampshire: what Medicaid covers

New Hampshire stopped covering GLP-1s prescribed solely for weight loss on January 1, 2026. The state told providers the drugs stay covered as part of a treatment plan for type 2 diabetes, cardiovascular events, severe sleep apnea or MASH.

Checked against the primary source August 25, 2026
What Medicaid in New Hampshire covers, and the criteria that apply.
Drug Position Criteria
Semaglutide Other indications only Not covered when prescribed solely for weight loss. Cardiovascular events and MASH continue Changed January 1, 2026
Tirzepatide Other indications only Not covered when prescribed solely for weight loss. Severe obstructive sleep apnea continues Changed January 1, 2026
Liraglutide Not covered Named in the notice. Weight management is its only approved use, so no other-indication route remains Changed January 1, 2026
If the answer is no. Around 45% of initial prior authorizations for these drugs are refused, and 35 to 45% of first-level appeals are overturned. A refusal is not the end of the process, and the cash-pay routes are priced on this site alongside it.

Sources

Every claim above is checked against the primary text, and the date is the day we last opened it.

  1. 1
    Change in Medicaid Coverage for GLP-1 Medications

    New Hampshire Division of Medicaid Services Primary text read and checked Checked August 25, 2026